Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 5:38 AM ET


Company Overview of United Laboratories, Inc.

Company Overview

United Laboratories, Inc., a pharmaceutical and healthcare company, develops, manufactures, and markets prescription, consumer healthcare, and personal care products in various therapeutic categories. The company offers various tablets, capsules, drops, syrups, injections, and powders. It develops and markets a range of ethical and consumer products in various therapeutic segments, including anti-allergy, anti-asthma-copd, anti-fibrinolytics, anti-infectives, anti-TB, cardiovascular, central nervous system, cosmetics, cough-cold, dermatologicals, dietetics, endometabolics, eye-ear, gastrointestinal, genito-urinary-nephro, hospital solutions, medical device, OB-gyne, oncology, oral care, soma...

66 United Street

Mandaluyong City,  1550


Founded in 1945


63 2 637 8873


63 2 637 1635

Key Executives for United Laboratories, Inc.

Chief Executive Officer and President
Age: 69
Senior Vice President of R&d
Assistant Vice President and Country General Manager of Myanmar
Compensation as of Fiscal Year 2015.

United Laboratories, Inc. Key Developments

United Laboratories and Debiopharm International Launch Pamorelin in the Philippines

United Laboratories (Philippines) and Debiopharm International (Switzerland) have entered into an distribution and commercialisation agreement for Pamorelin (triptorelin pamoate) in the Philippines, for the treatment of locally advanced and metastatic hormone-dependent prostate cancer; as an adjuvant to radiotherapy in high-risk localised and locally advanced prostate cancer and endometriosis.

Nipro Pharma Enters Partnership with United Laboratories to Target Asian Market

Nipro Pharma has entered a collaboration with United Laboratories (Philippines) to market the Japanese company's pharmaceutical treatments in the Asian market. Under the agreement, United Laboratories will first market Nipro's products in the Philippines. The partnership is expected to be positive for Nipro and United Laboratories. Nipro will be able to leverage the extensive network of United Laboratories, which is the Philippines' larger pharmaceutical firm. Both companies are aiming to tap rapidly growing demand for affordable and safe generics in the Philippines, which has seen other firms pile into the increasingly competitive space.

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact United Laboratories, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at